| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |